EMA Authorised: Roteas (edoxaban tosilate) — Berlin-Chemie AG

View source ↗

Summary

The European Medicines Agency authorised Roteas, a product containing edoxaban, for indications related to stroke prevention and venous thromboembolism, expandi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Venous Thromboembolism

Drugs mentioned

• Roteas (edoxaban)

Snippet

Status: Authorised. Therapeutic area: Stroke;Venous Thromboembolism. MAH: Berlin-Chemie AG. Decision date: 20/11/2023